NM_133263.4:c.164C>T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_133263.4(PPARGC1B):c.164C>T(p.Ala55Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,613,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133263.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPARGC1B | ENST00000309241.10 | c.164C>T | p.Ala55Val | missense_variant | Exon 2 of 12 | 1 | NM_133263.4 | ENSP00000312649.5 | ||
PPARGC1B | ENST00000394320.7 | c.164C>T | p.Ala55Val | missense_variant | Exon 2 of 11 | 1 | ENSP00000377855.3 | |||
PPARGC1B | ENST00000360453.8 | c.164C>T | p.Ala55Val | missense_variant | Exon 2 of 11 | 1 | ENSP00000353638.4 | |||
PPARGC1B | ENST00000403750.5 | c.89C>T | p.Ala30Val | missense_variant | Exon 2 of 11 | 2 | ENSP00000384403.1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251292Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135836
GnomAD4 exome AF: 0.000125 AC: 182AN: 1461760Hom.: 0 Cov.: 31 AF XY: 0.000124 AC XY: 90AN XY: 727192
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.164C>T (p.A55V) alteration is located in exon 2 (coding exon 2) of the PPARGC1B gene. This alteration results from a C to T substitution at nucleotide position 164, causing the alanine (A) at amino acid position 55 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at